News & Articles

EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need

New product is designed to protect consumers with the latest in food testing technology

Explore exclusive interviews, new methods, and free download to help optimize your 3D cell culture

Join us on Tuesday, October 27, to learn more about how SIFT-MS works, how it speeds up analysis, and how it can be validated successfully in accordance with ICH Q2(R1) Guidelines

Join us on Wednesday, October 28, to learn how SpyTag-SpyCatcher technology enables site-directed conjugation and rapid assembly of different antibody format

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

Streamlined solution features quality control reagent kits, robotic sample preparation, mass spectrometry analysis and data reporting software to transform analysis efficiency

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

We reveal the cell counters, LC systems and particle size analyzer that have earned one of these coveted awards based on exceptional reviewer feedback

Learn how high-throughput, real-time cell analysis can accurately detect and quantify virus-neutralizing antibodies and see how this technology is advancing COVID-19 research

Join us Thursday, October 22, to explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries

BotrytisAlert harnesses Mologic’s expert lateral flow technology to enable earlier disease intervention and prevent wide-spread crop failures

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2

Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions

Join us, Friday, October 23, to explore key technologies for sample prep, method development, and metabolomics projects in medical research

Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape

Join us on Friday, October 16, to explore automation technology, software integration and advanced methods for improved BMaD quality, security and traceability